MEDICINES CO's ticker is and the CUSIP is 584688AG0. A total of 42 filers reported holding MEDICINES CO in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $45,231,000,000 | +32.8% | 26,000,000 | -7.1% | 1.28% | +35.2% |
| Q3 2019 | $34,055,000,000 | -13.9% | 28,000,000 | -30.0% | 0.95% | +23.6% |
| Q2 2019 | $39,542,000,000 | +55.7% | 40,000,000 | +19.4% | 0.77% | -16.4% |
| Q4 2018 | $25,397,000,000 | +7.6% | 33,500,000 | +30.1% | 0.92% | +69.0% |
| Q3 2018 | $23,607,000,000 | -23.9% | 25,750,000 | -16.9% | 0.54% | -12.7% |
| Q2 2018 | $31,030,000,000 | +12.6% | 31,000,000 | +8.8% | 0.62% | +16.9% |
| Q1 2018 | $27,556,000,000 | -16.7% | 28,500,000 | -20.8% | 0.53% | -9.4% |
| Q4 2017 | $33,075,000,000 | +3032.1% | 36,000,000 | +3500.0% | 0.59% | +3806.7% |
| Q3 2017 | $1,056,000,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 3,000,000 | $2,762,000 | 2.59% |
| PT ASSET MANAGEMENT, LLC | 3,750,000 | $3,448,000 | 1.87% |
| ARISTEIA CAPITAL, L.L.C. | 32,500,000 | $29,921,000 | 1.27% |
| ZAZOVE ASSOCIATES LLC | 22,710,000 | $20,905,000 | 1.23% |
| PFM Health Sciences, LP | 34,471,000 | $31,692,000 | 0.75% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 24,215,000 | $22,262,000 | 0.63% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 36,000,000 | $33,075,000,000 | 0.59% |
| Partner Investment Management, L.P. | 479,000 | $440,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 4,808,000 | $4,398,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,315,000 | $29,732,000 | 0.30% |